Patents by Inventor Shigeharu YABE

Shigeharu YABE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11746331
    Abstract: An object of the present invention is to provide an endodermal cell population for obtaining optimal somatic cells as cell therapy preparations. The endodermal cell population of the present invention has a reduced content proportion of undifferentiated cells in the cell population and contains endodermal cells differentiable into optimal somatic cells as cell therapy preparations. Further, a somatic cell derived from the endodermal cell population of the present invention has excellent therapeutic effects as a cell therapy preparation.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: September 5, 2023
    Assignees: NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE
    Inventors: Masato Ibuki, Hitoshi Okochi, Shigeharu Yabe
  • Publication number: 20230174945
    Abstract: A method for inducing differentiation into pancreatic ? cells includes: a step (a) of culturing endodermal cells, which have been induced to differentiate from pluripotent stem cells, in the presence of a bone morphogenetic protein (BMP) signaling inhibitor, and retinoic acid or a retinoic acid analog to induce differentiation into primitive gut tube (PGT) cells; a step (b) of culturing the primitive gut tube (PGT) cells to induce differentiation into pancreatic endocrine precursor (EP) cells; and a step (c) of culturing the pancreatic endocrine precursor (EP) cells to induce differentiation into pancreatic ? cells, in which the step (b) and the step (c) are performed in the absence of ascorbic acid.
    Type: Application
    Filed: March 18, 2021
    Publication date: June 8, 2023
    Applicants: KANEKA CORPORATION, NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE
    Inventors: Keiichi KIMURA, Masato IBUKI, Hitoshi OKOCHI, Shigeharu YABE
  • Publication number: 20220017869
    Abstract: An object of the present invention is to provide an endodermal cell population for obtaining optimal somatic cells as cell therapy preparations. The endodermal cell population of the present invention has a reduced content proportion of undifferentiated cells in the cell population and contains endodermal cells differentiable into optimal somatic cells as cell therapy preparations. Further, a somatic cell derived from the endodermal cell population of the present invention has excellent therapeutic effects as a cell therapy preparation.
    Type: Application
    Filed: January 26, 2018
    Publication date: January 20, 2022
    Applicants: KANEKA CORPORATION, NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE
    Inventors: Masato IBUKI, Hitoshi OKOCHI, Shigeharu YABE
  • Publication number: 20210246427
    Abstract: A problem addressed by the present invention is to provide a method for producing pancreatic ? cells from endothermal cells that have been induced to differentiate from pluripotent stein cells, wherein the method allows the production of pancreatic ? cells of high quality, and to provide pancreatic progenitor (PP) cells, pancreatic endocrine precursor (EP) cells, and pancreatic ? cells produced by the above-mentioned method.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 12, 2021
    Applicants: KANEKA CORPORATION, NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE
    Inventors: Masato IBUKI, Hirotoshi MATSUTA, Hitoshi OKOCHI, Shigeharu YABE, Satsuki FUKUDA
  • Publication number: 20210246429
    Abstract: A problem addressed by the present invention is to provide a method for producing primitive gut tube cells from endothermal cells that have been induced to differentiate from pluripotent stein cells, wherein the method allows the production of pancreatic ? cells of high quality. The present invention provides a method for producing primitive gut tube (PGT) cells comprising a step of culturing, in the absence of a bone morphogenetic protein (BMP) signaling inhibitor, endodermal cells that have been induced to differentiate from pluripotent stem cells.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 12, 2021
    Applicants: KANEKA CORPORATION, NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE
    Inventors: Masato IBUKI, Hirotoshi MATSUTA, Hitoshi OKOCHI, Shigeharu YABE, Satsuki FUKUDA